ConductScience.org, home

Paper42016367

Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections.

Morrisette T and 24 others. Open Forum Infect Dis, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections. Papers, record 42016367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42016367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections.
PubMed
Journal
Open Forum Infect Dis
PubMed
Year
2026
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morrisette TTaylorhttps://orcid.org/0000-0002-1094-043X
2Stimes GTGrant Thttps://orcid.org/0000-0003-2959-8184
3Alvira-Arill GRGustavo Rhttps://orcid.org/0000-0003-3138-8848
4Lockowitz CRChristine Rhttps://orcid.org/0000-0002-5881-2752
5Yuenger VValerie
6Facer EEEvan E
7Huang AAlex
8Holger DJDana Jhttps://orcid.org/0000-0001-7171-7015
9Althubyani AAAli Ahttps://orcid.org/0009-0009-7125-9830
10El Ghali AAmerhttps://orcid.org/0000-0003-1744-0048
11Kesner JJacob
12Kufel WDWesley Dhttps://orcid.org/0000-0001-7703-096X
13Santevecchi BABarbara Ahttps://orcid.org/0000-0001-5239-8303
14Venugopalan VVeenahttps://orcid.org/0000-0002-9424-5783
15Olney KBKatie Bhttps://orcid.org/0000-0001-7536-9070
16Newland JGJason Ghttps://orcid.org/0000-0001-9979-7993
17Shelley JJamee
18Walsh LLauren
19Wilson WSWilliam Shttps://orcid.org/0000-0001-5837-066X
20Dassner AMAimee M

Source PubMed

See all 25 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118929686Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform2009https://conductscience.org/library/papers/18929686PubMed
233130270Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review.Clin Microbiol Infect2021https://conductscience.org/library/papers/33130270PubMed
335734203Disparities Associated with Sepsis Mortality in Critically Ill Children.J Pediatr Intensive Care2022https://conductscience.org/library/papers/35734203PubMed
440019735Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World Use.Paediatr Drugs2025https://conductscience.org/library/papers/40019735PubMed
532265601Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.J Pediatr Pharmacol Ther2020https://conductscience.org/library/papers/32265601PubMed
622025597Extrapolation of adult data and other data in pediatric drug-development programs.Pediatrics2011https://conductscience.org/library/papers/22025597PubMed
738365226Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System.Am J Health Syst Pharm2024https://conductscience.org/library/papers/38365226PubMed
836375099
Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria Infections.
Pediatr Infect Dis J2022https://conductscience.org/library/papers/36375099PubMed
930909507A Review of the Clinical Pharmacokinetics of Polymyxin B.Antibiotics (Basel)2019https://conductscience.org/library/papers/30909507PubMed
1039108079Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.Clin Infect Dis2024https://conductscience.org/library/papers/39108079PubMed
1134901302Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.Open Forum Infect Dis2021https://conductscience.org/library/papers/34901302PubMed
1236763243The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study.Infect Dis Ther2023https://conductscience.org/library/papers/36763243PubMed
1335065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
1438927230
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients.
Antibiotics (Basel)2024https://conductscience.org/library/papers/38927230PubMed
1525649155AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.Clin J Am Soc Nephrol2015https://conductscience.org/library/papers/25649155PubMed
1633289506Understanding Pediatric Drug Lag Time: Review of Selected Drug Package Inserts.J Pediatric Infect Dis Soc2021https://conductscience.org/library/papers/33289506PubMed
1735241917Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection.Infect Drug Resist2022https://conductscience.org/library/papers/35241917PubMed
1834430671Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa.Open Forum Infect Dis2021https://conductscience.org/library/papers/34430671PubMed
1911389297Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.Pediatrics2001https://conductscience.org/library/papers/11389297PubMed
2039847495Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children.J Pediatric Infect Dis Soc2025https://conductscience.org/library/papers/39847495PubMed

See all 48 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42016367

GET https://conductscience.org/api/papers/v1/42016367/authors?page=2